B. Braun said it has launched the Supply Assurance Program to boost supply chain resiliency and ensure uninterrupted patient ...

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen explores the potential over-reliance on a medical device ...

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Peijia's TaurusTrio TAV system wins NMPA approval, revolutionizing severe AR treatment with Jenavalve's locator technology.

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.

The Senate has rejected bipartisan ACA subsidy bills as millions face doubled premiums when financial assistance expires at ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

CMS AI Playbook v4 mandates prompt safeguards and auditable data lineage for generative AI in hospitals. Non-compliance risks ...

Montagu and Kohlberg will acquire Teleflex Medical OEM for $1.5B in a carve-out deal, closing in 2026. Private equity firms ...

Ajinomoto launches CELLiST AAV Production Supplement 1, boosting gene therapy viral vector productivity by 1.3-2x.

Intuitive's da Vinci SP system secures FDA clearance for hernia, gallbladder, appendix surgeries amid growing competition.

Neuralink hires FDA executive David McMullen as head of medical affairs to advance brain-computer interface development.